Yanguo Kong
- Health Informatics top 5%
-
- Pituitary Gland Disorders and Treatments 7
-
- Pain Management and Opioid Use 3
-
- Cancer, Hypoxia, and Metabolism 2
- MicroRNA in disease regulation 2
-
- Pharmacology and Obesity Treatment 2
-
- Glioma Diagnosis and Treatment 2
-
- RNA Interference and Gene Delivery 2
-
- Neuroblastoma Research and Treatments 2
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Yanguo Kong
22 papers receiving 327 citations
Peers
Comparison fields: 5 of 90
- Health Informatics 25
- Internal Medicine 12
- Endocrinology, Diabetes and Metabolism 53
- Anesthesiology and Pain Medicine 17
- Cancer Research 42
Countries citing papers authored by Yanguo Kong
This map shows the geographic impact of Yanguo Kong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanguo Kong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanguo Kong more than expected).
Fields of papers citing papers by Yanguo Kong
This network shows the impact of papers produced by Yanguo Kong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanguo Kong. The network helps show where Yanguo Kong may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yanguo Kong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Artificial intelligence: a key to relieve China's insufficient and unequally-distributed medical resources. | 2019 | 32 |
| 2 | Opioid receptor mu 1 (OPRM1) A118G polymorphism (rs1799971) and postoperative nausea and vomiting. | 2018 | 16 |
| 3 | 2017 | 6 | |
| 4 | 2017 | 24 | |
| 5 | 2017 | 16 | |
| 6 | 2017 | 3 | |
| 7 | 2017 | 16 | |
| 8 | 2017 | 69 | |
| 9 | 2017 | 8 | |
| 10 | 2017 | 3 | |
| 11 | 2017 | 34 | |
| 12 | 2015 | 3 | |
| 13 | 2014 | 3 | |
| 14 | 2010 | 55 | |
| 15 | [In vivo tracking of bone marrow mesenchymal stem cells labeled with superparamagnetic iron oxide after cerebral ischemia in rats by magnetic resonance imaging]. | 2007 | 3 |
| 16 | [Distribution and expression of peroxisome proliferator activated receptor gamma in human pituitary adenomas]. | 2006 | 2 |
| 17 | [Expressive level of vascular endothelial growth factor in peripheral blood in patients with pituitary adenomas]. | 2004 | 3 |
| 18 | Elevated soluble epidermal growth factor receptor level in pituitary adenoma and carcinoma. | 2004 | 6 |
| 19 | [Measurement of soluble CD44v6 in peripheral blood as assistant diagnosis of invasive pituitary adenomas]. | 2003 | 4 |
| 20 | [Measurement of epidermal growth factor receptor concentration in the pre- and postoperative serum in patients with meningiomas]. | 2002 | 3 |
About Yanguo Kong
Yanguo Kong is a scholar working on Health Informatics, Anesthesiology and Pain Medicine and Endocrinology, Diabetes and Metabolism, having authored 22 papers that have together received 336 indexed citations. Recurring topics across this work include Pituitary Gland Disorders and Treatments (7 papers), Pain Management and Opioid Use (3 papers), Cancer, Hypoxia, and Metabolism (2 papers), Pharmacology and Obesity Treatment (2 papers), Glioma Diagnosis and Treatment (2 papers), RNA Interference and Gene Delivery (2 papers), Neuroblastoma Research and Treatments (2 papers) and MicroRNA in disease regulation (2 papers). The work is most often cited by research in Health Informatics (25 citations), Internal Medicine (12 citations) and Endocrinology, Diabetes and Metabolism (53 citations). Yanguo Kong has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Xiangyi Kong, Lijuan Su, Newton Howard, Shun Gong, Jingping Wang, Wenyue Liu, Hao Deng, Chen Li, Renzhi Wang and Guilin Li. Their work appears in journals such as Medicine, Oncotarget and Human Gene Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.